ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Translational science at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

47 organizations at ELRIG Drug Discovery 2026 present work in translational science: 32 technology and service providers, 9 academic, government and non-profit bodies and 6 drug developers. Between them they bring 47 presentations to the program. Most represented: AstraZeneca (11 on the program), University College London (3 on the program), Pharmaron (3 on the program). As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–12 of 47 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
University College London London, UK
ucl.ac.uk Academic & healthcare Public research university in London.	Talk Wed Oct 14 3:45pm–4:15pm Therapeutic application of “ready-made” base-edited CAR T cells in leukaemia Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm Mindful Conversations: Building Trust with Black Communities as a Foundation for Inclusive Dementia Research Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development Talk Thu Oct 15 3:00pm–3:30pm Bridging the Translation Gap: How Core Facilities Turn High‑Dimensional Cytometry Into Clinically Meaningful Outcomes Auditorium 1 From multi-omics to clinical outcomes: Insights for drug development
Pharmaron Beijing, China	◆Conference Partner
pharmaron.com CROs & CDMOsConference Partner Contract research, development and manufacturing provider covering small molecules, biologics and cell and gene therapy, with integrated discovery teams from hit to candidate.	Booth Exhibiting at Booth D12, D13 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Thu Oct 15 10:50am–10:55am Track Chair - AI in medicinal chemistry How AI and machine learning are changing drug discovery, covering compound quality, links to lab validation and newer AI tools. Auditorium 3 with IUPAC, Royal Society of Chemistry Talk Thu Oct 15 11:25am–11:55am A CNS‑Focused Approach to Selective PARP1 Drug Discovery How chemists designed a selective, brain-penetrant oral inhibitor for brain cancers, aiming to avoid the blood toxicities that limit older drugs. Exhibition Hall Theatre
LifeArc London, UK	◆Partner
lifearc.org Gov/NGOPartner UK medical research charity that funds and runs translational research and drug discovery to move science toward patients.	Booth Exhibiting at Booth CZ03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, Novo Nordisk, Novartis Talk Wed Oct 14 9:25am–10:10am Plenary Keynote - Where Need Meets Momentum: The Next 20 Years Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
Imperial College London London, UK
imperial.ac.uk Academic & healthcare London research university in science, engineering, medicine and business.	Talk Thu Oct 15 11:55am–12:25pm Beyond Protein Expression: Singel-Cell Spatial Protein Organization in Autoimmune Disease Auditorium 1 From multi-omics to clinical outcomes: Insights for drug development Talk Thu Oct 15 3:00pm–3:30pm Developing a Drug Pipeline for a Multi-arm Multi-stage Platform Trial in Clinical Alzheimer’s Disease Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development
UK Dementia Research Institute London, UK
ukdri.ac.uk Academic & healthcare National research institute studying dementia and neurodegenerative disease through centres hosted at UK universities.	Chair Thu Oct 15 10:50am–10:55am Track Chair - Inclusive translational approaches to accelerate equitable neuroscience drug development What it takes to move neurological drugs through clinical trials, from trial design and patient grouping to diverse enrolment and regulatory expectations. Exhibition Hall Theatre with Northumbria University Talk Thu Oct 15 10:55am–11:25am From High throughput Phenotypic Drug Screening to Clinical Trials: Advancing ALS/MND Therapeutics Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development
University of Edinburgh Edinburgh, UK
ed.ac.uk Academic & healthcare Public research university in Edinburgh, Scotland.	Talk Wed Oct 14 2:00pm–2:30pm Intratarget Microdosing in the human lung to accelerate therapeutic development Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges Talk Thu Oct 15 3:00pm–3:30pm Deep Machine Learning on Chemical Synthesis Auditorium 3 AI in medicinal chemistry
Domainex Cambridge, UK
domainex.co.uk CROs & CDMOs Integrated drug discovery services partner covering target expression, hit identification and lead optimisation through to preclinical candidates.	Booth Exhibiting at Booth J34 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with AstraZeneca Talk Wed Oct 14 2:30pm–2:35pm Technology Spotlight Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges
Medicines Discovery Catapult Alderley Park, UK
md.catapult.org.uk Gov/NGO UK national centre helping drug discovery entrepreneurs validate ideas and de-risk investment through its expertise, technology and national programmes.	Booth Exhibiting at Booth G28 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 4:15pm–4:30pm Advancing Drug Discovery Through Radiopharmaceutical Innovation Why radioactive drugs that both image and treat tumours can confirm a drug reaches its target, and what manufacturing hurdles remain. Auditorium 3 Talk Thu Oct 15 2:30pm–3:00pm Mind the Gap: Maximising Sample Value from Collection to Translation - A new route to unlock the translational potential of human biological samples Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery
Apollo Therapeutics Cambridge, UK
apollotx.com Biotech Biotech developing a portfolio of medicines built on academic science, with programmes in oncology and immunology.	Talk Wed Oct 14 2:40pm–3:10pm From Idea to Clinic: Lessons from Apollo Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges
AU ARUK UCL Drug Discovery Institute London, UK
Academic & healthcare Drug discovery institute at University College London, funded by Alzheimer's Research UK, pursuing new targets for neurodegenerative disease.	Panel Thu Oct 15 3:30pm–4:00pm Panel session - Who Gets to Benefit? Making Neuroscience Drug Development Truly Equitable Exhibition Hall Theatre Inclusive translational approaches to accelerate equitable neuroscience drug development
Calluna Pharma
callunapharma.com Biotech Develops antibody therapies for immune-driven disease, including an anti-S100A4 antibody for chronic inflammatory and fibrotic conditions.	Talk Wed Oct 14 3:45pm–4:15pm Development of CAL1021 - a humanized monoclonal antibody targeting S100A4 to inhibit proinflammatory and profibrotic signaling in chronic fibrotic diseases Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges